Package 16571-744-09

{"route": ["ORAL"], "spl_id": "9f8d9c4c-f326-4784-8ea4-f791613077f7", "openfda": {"upc": ["0316571743094"], "unii": ["V92SO9WP2I"], "rxcui": ["197738", "197739"], "spl_set_id": ["58c4cb1f-59b8-4be9-a222-2264ca077d93"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 CONTAINER (16571-744-03)", "package_ndc": "16571-744-03", "marketing_start_date": "20201006"}, {"sample": false, "description": "90 TABLET in 1 CONTAINER (16571-744-09)", "package_ndc": "16571-744-09", "marketing_start_date": "20201006"}], "brand_name": "Glycopyrrolate", "product_id": "16571-744_9f8d9c4c-f326-4784-8ea4-f791613077f7", "dosage_form": "TABLET", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "16571-744", "generic_name": "Glycopyrrolate", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Glycopyrrolate", "active_ingredients": [{"name": "GLYCOPYRROLATE", "strength": "2 mg/1"}], "application_number": "NDA012827", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20201006", "listing_expiration_date": "20271231"}